###begin article-title 0
Homocysteine Levels in Chronic Gastritis and Other Conditions: Relations to Incident Cardiovascular Disease and Dementia
###end article-title 0
###begin p 1
###xml 0 10 0 10 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Background</italic>
###xml 357 365 357 365 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Methods</italic>
###xml 400 401 400 401 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 426 435 426 435 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 915 923 915 923 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Results</italic>
###xml 1531 1543 1530 1542 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Conclusions</italic>
###xml 426 435 <span type="species:ncbi:210">H. pylori</span>
###xml 1180 1192 <span type="species:ncbi:9606">participants</span>
Background Homocysteine levels in circulation are determined by several factors and hyperhomocysteinemia is reportedly associated with cardiovascular diseases and dementia. The aim of this study is to determine the relation of chronic gastritis and other conditions to homocysteine levels and their relation to incident cardiovascular diseases and dementia. Methods An adult population-based cohort (N = 488) was screened for H. pylori infection, gastro-duodenitis (endoscopic biopsies), disease history, and lifestyle factors. Blood samples were analyzed for pepsinogen I and II (gastric function), vitamin B12, folate, homocysteine, and cystatin C (renal function). The methylenetetrahydrofolate reductase C677T polymorphism reportedly associated with hyperhomocysteinemia was analyzed by pyrosequencing. Incident cardiovascular diseases and dementia were monitored during a median follow-up interval of 10 years. Results At baseline, there was a positive relation of S-homocysteine to male gender, age, S-cystatin C, methylenetetrahydrofolate reductase 677TT genotype and atrophic gastritis. During follow-up, cardiovascular diseases occurred in 101/438 and dementia in 25/488 participants, respectively. Logistic regression analysis (adjusting for gender, age at baseline, follow-up interval, BMI, smoking, alcohol consumption, NSAID use, P-cholesterol, and P-triglycerides) showed an association of S-homocysteine higher than 14.5 mumol/l to cardiovascular diseases (OR 2.05 [95% c.i. 1.14-3.70]), but not to dementia overall. Conclusions Gender, age, vitamin B12, folate, renal function, atrophic gastritis and the methylenetetrahydrofolate 677TT genotype were significant determinants of homocysteine levels, which were positively related to incident cardiovascular diseases.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 71 72 71 72 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 306 307 306 307 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 504 505 504 505 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 674 675 674 675 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
Homocysteine (Hcy) metabolism is dependent on several factors, such as S-adenosylmethionine (SAM), vitamin B12 as a cofactor, and methyltetrahydrofolate as the substrate. Deficiency of these or of other substances, as well as enzymatic defects, disturb the metabolism and may lead to hyperhomocysteinemia [1]. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, acting as methyl donor in the conversion of Hcy to methionine [1]. The MTHFR single nucleotide polymorphism (SNP) C677T (SNPdb ID: rs1801133) is known to yield an enzyme with reduced activity, which leads to mild hyperhomocysteimia [2].
###end p 4
###begin p 5
###xml 74 75 74 75 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 193 194 193 194 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 195 196 195 196 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 273 274 273 274 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 334 335 334 335 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 337 339 337 339 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 355 357 355 357 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 359 361 359 361 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 420 422 420 422 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 424 426 424 426 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 572 573 571 572 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 575 576 574 575 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 578 579 577 578 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 581 583 580 582 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 584 586 583 585 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 588 590 587 589 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
Hyperhomocysteinemia may cause damage to the intima of the vascular wall [3]. It has been linked to cardiovascular diseases, dementia, diabetes mellitus (DM), hypothyreosis, and renal disease [3-7]. The levels of Hcy in circulation are inversely related to renal function [8]. The association between Hcy and cardiovascular diseases [9, 10] and dementia [11, 12] has been shown in several studies, but is controversial [13, 14]. The cut-off value for the Hcy concentration used to define hyperhomocysteinemia is poorly defined. Levels around 14-15 mumol/l have been used [3, 5, 7, 10-12, 15].
###end p 5
###begin p 6
###xml 210 212 210 212 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 214 216 214 216 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 395 414 395 414 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori</italic>
###xml 416 425 416 425 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 560 562 560 562 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 564 566 564 566 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 619 628 619 628 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 666 668 666 668 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 395 414 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 416 425 <span type="species:ncbi:210">H. pylori</span>
###xml 619 628 <span type="species:ncbi:210">H. pylori</span>
Deficiencies of vitamin B12 and folate are common etiologies of hyperhomocysteinemia. Untreated celiac disease is frequently associated with folate deficiency and, to a lower rate, with vitamin B12 deficiency [16, 17]. A frequent cause of vitamin B12 deficiency is atrophy of the gastric corpus mucosa, which leads to reduced intrinsic factor secretion, i.e., latent or overt pernicious anemia. Helicobacter pylori (H. pylori) infection per se, irrespective of atrophy of the gastric mucosa, was found to be associated with reduced vitamin B12 in circulation [18, 19]. However, a meta-analysis showed no association of H. pylori infection to coronary heart disease [20].
###end p 6
###begin p 7
###xml 106 115 106 115 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 106 115 <span type="species:ncbi:210">H. pylori</span>
The objective of this 10-year follow-up study of a population-based cohort was to investigate what impact H. pylori infection, chronic gastritis, MTHFR C677T SNP, renal dysfunction, and some other conditions have on variations in Hcy levels in circulation and, furthermore, to explore the relations of Hcy levels to subsequent development of cardiovascular diseases and dementia.
###end p 7
###begin title 8
Methods
###end title 8
###begin title 9
Study Population and Follow-Up
###end title 9
###begin p 10
###xml 163 175 <span type="species:ncbi:9606">participants</span>
The study was performed in accordance with the Helsinki Declaration and was approved by the local ethics committee. Informed written consent was obtained from all participants.
###end p 10
###begin p 11
###xml 45 54 45 54 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 101 103 101 103 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 105 107 105 107 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 45 54 <span type="species:ncbi:210">H. pylori</span>
###xml 195 200 <span type="species:ncbi:9606">women</span>
###xml 205 208 <span type="species:ncbi:9606">men</span>
###xml 421 433 <span type="species:ncbi:9606">participants</span>
###xml 445 457 <span type="species:ncbi:9606">participants</span>
###xml 514 519 <span type="species:ncbi:9606">women</span>
###xml 528 531 <span type="species:ncbi:9606">men</span>
###xml 726 738 <span type="species:ncbi:9606">participants</span>
The prevalence of gastritis, duodenitis, and H. pylori infection in this cohort have been published [21, 22]. Five-hundred-and-one randomly selected subjects (age 35-85 years and equal number of women and men at selection) in the general population underwent esophago-gastro-duodenoscopy (EGD) with biopsy. A complete histomorphological examination of biopsies from both the gastric corpus and antrum was obtained in 488 participants. These 488 participants make up the cohort studied here and which comprises 225 women and 263 men with median ages of 62 (min 38-max 85) years and 60 (37-82) years, respectively, at baseline. Histomorphological examination of biopsies from the second part of the duodenum was achieved in 474 participants.
###end p 11
###begin p 12
###xml 17 29 <span type="species:ncbi:9606">participants</span>
###xml 490 502 <span type="species:ncbi:9606">participants</span>
###xml 529 536 <span type="species:ncbi:9606">patient</span>
At baseline, the participants received a self-administered questionnaire exploring details about previous and current diseases, body weight, and height, current smoking, use of alcohol, and current medications including the use of aspirin (including low-dose) or other potentially ulcerogenic NSAIDs. Eight years (minimum) after baseline, the same questionnaire was distributed. In addition, in-hospital diagnoses recorded before and after baseline including causes of death among deceased participants were extracted from local patient files (including those of the Memory Reception, Department of Geriatric Medicine) as well as from the records of Statistics Sweden (SCB) and the Swedish National Board of Health and Welfare. Nationwide reporting to the latter goes back to 1964 (full cover by 1987). Files were screened up to 2005.
###end p 12
###begin p 13
###xml 80 91 <span type="species:ncbi:9606">participant</span>
In case of incident cardiovascular diseases, one diagnosis was assigned to each participant. Myocardial infarction was given the highest priority. The priority of other diagnoses in descending order was: ischemic heart disease (angina pectoris), aortic or other arterial aneurysm, transient ischemic attack (TIA) or stroke, and cardiac arrhythmia and/or heart failure; all without a registered diagnosis of myocardial infarction. Hypertension as the sole diagnosis was not included since primarily this diagnosis is set in primary health care, and is probably underreported and latent/subclinical in the general population.
###end p 13
###begin p 14
###xml 27 39 <span type="species:ncbi:9606">participants</span>
###xml 463 475 <span type="species:ncbi:9606">participants</span>
###xml 481 486 <span type="species:ncbi:9606">women</span>
###xml 495 498 <span type="species:ncbi:9606">men</span>
In the total cohort of 488 participants, 50 had a history of a cardiovascular disease at baseline (myocardial infarction ten, angina pectoris 17, TIA/stroke four, and cardiac arrhythmia and/or heart failure 19). None had known dementia, since that precluded participation. Ninety-nine of 485 responders were current smokers, 78 of 476 responders used spirits and/or wine every week, and 81 of 476 responders used aspirin or other NSAID every week. There were 438 participants (207 women and 231 men, age 59.4 (36.8-84.9) years) with no history of a cardiovascular disease or dementia at baseline (smokers 93 of 435 responders; use of alcohol every week 71 of 429 responders; use of aspirin or other NSAID every week 60 of 427 responders).
###end p 14
###begin p 15
###xml 16 28 <span type="species:ncbi:9606">participants</span>
###xml 130 142 <span type="species:ncbi:9606">participants</span>
###xml 228 239 <span type="species:ncbi:9606">participant</span>
###xml 299 311 <span type="species:ncbi:9606">participants</span>
###xml 513 525 <span type="species:ncbi:9606">participants</span>
At baseline, 14 participants had DM (one type 1 and 13 type 2). During the follow-up period, four developed type 2 DM. Twenty-six participants had thyroid disease, classified as hypothyroid disease in six. During follow-up, one participant underwent surgery for non-specified thyroid disease. Three participants had a history of renal disease (one operated and one non-operated for cystic disease, and one operated for renal carcinoma). During follow-up, nephritis was diagnosed in one and renal carcinoma in two participants.
###end p 15
###begin title 16
###xml 30 39 30 39 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 30 39 <span type="species:ncbi:210">H. pylori</span>
Histological Examinations and H. pylori Status
###end title 16
###begin p 17
###xml 221 223 221 223 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 346 355 346 355 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 357 359 357 359 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 579 581 579 581 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 346 355 <span type="species:ncbi:210">H. pylori</span>
Routinely prepared biopsy sections (three biopsies from the corpus, antrum and second part of the duodenum) were stained with hematoxylin-eosin, Alcian blue-periodic acid-Schiff, and Giemsa stain as previously described [21]. Gastritis was classified according to the Sydney system, i.e., severity, topographic distribution and the occurrence of H. pylori [23]. Considering glandular atrophy of the gastric corpus mucosa, moderate to severe atrophy was taken into account in the present study. Atrophy of the duodenal mucosa was histologically classified according to Alexander [24], and in the present study it was defined as grade III or grade IV.
###end p 17
###begin p 18
An experienced pathologist (F.P) who had no information about other data performed the microscopic examinations.
###end p 18
###begin p 19
###xml 0 9 0 9 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 154 156 154 156 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 222 231 222 231 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 345 354 345 354 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 381 383 381 383 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 0 9 <span type="species:ncbi:210">H. pylori</span>
###xml 222 231 <span type="species:ncbi:210">H. pylori</span>
###xml 296 308 <span type="species:ncbi:9606">participants</span>
###xml 345 354 <span type="species:ncbi:210">H. pylori</span>
H. pylori status was classified as previously described, i.e., positive if at least one of serology, histology and urease-test on fresh biopsy specimens [21] indicated infection. The study was non-interventional regarding H. pylori infection. However, the infection was treated at baseline in 15 participants who at screening were shown to have H. pylori associated ulcer disease [21]. None of these had atrophic gastritis.
###end p 19
###begin title 20
Blood Analyses
###end title 20
###begin p 21
###xml 279 282 272 273 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 680 683 671 672 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 615 626 <span type="species:ncbi:3704">horseradish</span>
At baseline, blood samples were collected in a fasting state immediately preceding EGD. The samples were stored at -80degreesC. Sera were analyzed (Biohit Diagnostics, Helsinki, Finland) for vitamin B12 (pmol/l), folate (nmol/l) and Hcy (mumol/l) concentrations with the Immulite(R) 1000 method (DPC, Los Angeles, CA, USA) according to the manufacturer's instructions. Samples were run at the same time to minimize assay variability. Pepsinogens in serum were measured with a sandwich enzyme immunoassay (ELISA) utilizing a pepsinogen I (PGI) and pepsinogen II (PGII) specific capture antibody, respectively, and a horseradish peroxidase (HRP) detection antibody (from GastroPanel(R), Biohit Diagnostics, Helsinki, Finland). There is no cross reactivity between the two assays. The reference interval is 30.0-120.0 mug/l for PGI, 3.0-10.0 mug/l for PGII and 3.0-20.0 for the ratio PGI/PGII. Values of PGI/PGII lower than 3.0 were considered as indicative of significant atrophy of the gastric corpus mucosa.
###end p 21
###begin p 22
P-total cholesterol (mmol/l) and P-triglycerides (mmol/l) were measured with the Hitachi 717 (Boehringer Mannheim Scandinavia AB, Stockholm, Sweden) using specific reagent 1.
###end p 22
###begin p 23
Cystatin C in serum was analyzed with Advia 1650 (Bayer AB, Gothenburg, Sweden) using reagent DakoCystatin C at the Dept. of Clinical Chemistry, University Hospital, Linkoping, Sweden (reference interval for ages 1-50 years : 0.7-1.21 mg/l and for ages >50 years: 0.84-1.55 mg/l).
###end p 23
###begin title 24
MTHFR SNP 677 Genotype Analysis
###end title 24
###begin p 25
###xml 126 128 126 128 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 908 910 878 880 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
DNA from blood samples (whole blood, plasma, or serum) was extracted, amplified and quality assessed as previously described [25]. Primers for MTHFR C677T (rs1801133) pyrosequencing analysis were designed based on the available MTHFR genomic sequence (GenBank accession number NT_021937, region: 6388104-6400540) using the PSQ Assay design software (Biotage, Uppsala, Sweden). The primers Biotin-MTHFR677.se (ccgaagcagggagctttga), MTHFR677.as (caagtgatgcccatgtcg), and sequencing primer Seq-MTHFR677 (cgtgatgatgaaatcg) were used. PCR products were obtained using the HotStarTaq Plus Mastermix kit (Qiagen, Hilden, Germany) following the manufacturer's instructions, using 5 pmol of each primer, and the PCR program: 95degreesC 5 min; 35 cycles of 95degreesC 30 s, 60degreesC 30 s, 72degreesC 1 min; final extension 72degreesC 10 min. The PCR products were analyzed by pyrosequencing as previously described [25].
###end p 25
###begin title 26
Statistical Analyses
###end title 26
###begin p 27
###xml 709 711 709 711 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> P</italic>
Numerical data were summarized as median (min-max) unit. The Mann-Whitney U-test was used for comparisons of continuous data between groups while Fisher's exact test was used for dichotomous data. Correlations were tested with Spearman's rank correlation test. A general linear model (GLM) was used to identify factors with impact on S-Hcy concentrations. Logistic regression analysis was performed in which incident cardiovascular diseases overall or dementia overall were included as the dependent variable. Goodness-of-fit was tested with the Hosmer-Lemeshow's method. Coefficients in GLM and odds ratios (OR) in logistic regression are given with [95% confidence intervals]. In every analysis, a two-sided P-value of <0.05 was regarded as significant.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 85 94 85 94 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 143 152 143 152 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 204 213 204 213 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 334 343 334 343 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 17 29 <span type="species:ncbi:9606">participants</span>
###xml 85 94 <span type="species:ncbi:210">H. pylori</span>
###xml 143 152 <span type="species:ncbi:210">H. pylori</span>
###xml 204 213 <span type="species:ncbi:210">H. pylori</span>
###xml 303 315 <span type="species:ncbi:9606">participants</span>
###xml 334 343 <span type="species:ncbi:210">H. pylori</span>
###xml 376 388 <span type="species:ncbi:9606">participants</span>
###xml 441 453 <span type="species:ncbi:9606">participants</span>
###xml 599 611 <span type="species:ncbi:9606">participants</span>
###xml 688 700 <span type="species:ncbi:9606">participants</span>
###xml 825 837 <span type="species:ncbi:9606">participants</span>
At baseline, 246 participants had histologically normal gastric mucosa with negative H. pylori status, 209 had chronic gastritis with positive H. pylori status, and 33 had chronic gastritis with negative H. pylori status. Atrophy of the corpus mucosa was diagnosed histomorphologically in 21 of the 488 participants (15 with positive H. pylori status). Twenty of 474 examined participants had a subnormal PGI/PGII value (<3.0) and 28 of 475 participants had atrophy either according to histological examination and/or the PGI/PGII value. Villous atrophy of the duodenal mucosa was diagnosed in nine participants. The distribution of the MTHFR 677 genotype among 483 successfully analyzed participants was 50.1% CC, 38.5% TC, and 11.4% TT while an S-Cystatin C concentration above the reference range was present in 18 of 473 participants examined.
###end p 29
###begin p 30
###xml 54 55 54 55 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Spearman analysis showed a weak although significant (P < 0.001) correlation between age and S-Hcy (rho = 0.26), age and S-cystatin C (rho = 0.40), S-Hcy and S-cystatin C (rho = 0.22), S-vitamin B12 and S-Hcy (rho = -0.28) and S-folate and S-Hcy (rho = -0.24).
###end p 30
###begin p 31
###xml 143 144 141 142 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 304 305 302 303 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 35 40 <span type="species:ncbi:9606">women</span>
###xml 49 52 <span type="species:ncbi:9606">men</span>
###xml 110 115 <span type="species:ncbi:9606">women</span>
###xml 124 127 <span type="species:ncbi:9606">men</span>
###xml 202 207 <span type="species:ncbi:9606">women</span>
###xml 216 219 <span type="species:ncbi:9606">men</span>
###xml 271 276 <span type="species:ncbi:9606">women</span>
###xml 285 288 <span type="species:ncbi:9606">men</span>
S-Hcy concentrations were lower in women than in men (12.0 (2.9-35.7) mumol/l vs 13.9 (5.8-50.0) mumol/l; 222 women and 257 men were examined; P < 0.001) and S-vitamin B12 concentrations were higher in women than in men (288 (118-789) pmol/l vs. 259 (98-742) pmol/l; 208 women and 233 men were examined; P = 0.005). S-folate and S-cystatin C concentrations did not differ between the sexes.
###end p 31
###begin p 32
###xml 106 107 106 107 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 116 117 116 117 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 231 240 231 240 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 562 563 560 561 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 573 580 571 578 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 580 679 578 677 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">S-Hcy concentrations in participants with condition reportedly associated with hyperhomocysteinemia</p>
###xml 580 679 578 677 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">S-Hcy concentrations in participants with condition reportedly associated with hyperhomocysteinemia</p></caption>
###xml 679 708 677 706 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Condition present at baseline</th>
###xml 708 736 706 734 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No. of participants examined</th>
###xml 736 777 734 774 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">P-homocysteine, &#956;mol/l, median (min&#8211;max)</th>
###xml 777 778 774 775 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 777 860 774 857 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic> (Mann&#8211;Whitney U-test) when compared to participants with none of these conditions</th>
###xml 679 860 677 857 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Condition present at baseline</th><th align="left">No. of participants examined</th><th align="left">P-homocysteine, &#956;mol/l, median (min&#8211;max)</th><th align="left"><italic>P</italic> (Mann&#8211;Whitney U-test) when compared to participants with none of these conditions</th></tr>
###xml 679 860 677 857 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Condition present at baseline</th><th align="left">No. of participants examined</th><th align="left">P-homocysteine, &#956;mol/l, median (min&#8211;max)</th><th align="left"><italic>P</italic> (Mann&#8211;Whitney U-test) when compared to participants with none of these conditions</th></tr></thead>
###xml 860 877 857 874 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Diabetes mellitus</td>
###xml 877 879 874 876 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13</td>
###xml 879 895 876 892 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15.4 (11.0&#8211;29.0)</td>
###xml 895 899 892 896 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.01</td>
###xml 860 899 857 896 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Diabetes mellitus</td><td char="." align="char">13</td><td char="(" align="char">15.4 (11.0&#8211;29.0)</td><td char="." align="char">0.01</td></tr>
###xml 899 912 896 909 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hypothyreosis</td>
###xml 912 913 909 910 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6</td>
###xml 913 928 910 925 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10.6 (9.6&#8211;14.4)</td>
###xml 928 932 925 929 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.23</td>
###xml 899 932 896 929 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Hypothyreosis</td><td char="." align="char">6</td><td char="(" align="char">10.6 (9.6&#8211;14.4)</td><td char="." align="char">0.23</td></tr>
###xml 986 987 983 984 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 932 987 929 984 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Renal dysfunction (S-cystatin C above reference range)<sup>a</sup></td>
###xml 987 989 984 986 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">17</td>
###xml 989 1004 986 1001 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16.4 (9.4&#8211;29.6)</td>
###xml 1004 1008 1001 1005 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.01</td>
###xml 932 1008 929 1005 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Renal dysfunction (S-cystatin C above reference range)<sup>a</sup></td><td char="." align="char">17</td><td char="(" align="char">16.4 (9.4&#8211;29.6)</td><td char="." align="char">0.01</td></tr>
###xml 1029 1030 1026 1027 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1008 1030 1005 1027 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">MTHFR 677 TT genotype<sup>a</sup></td>
###xml 1030 1032 1027 1029 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">51</td>
###xml 1032 1047 1029 1044 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13.0 (7.6&#8211;50.0)</td>
###xml 1047 1051 1044 1048 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13</td>
###xml 1008 1051 1005 1048 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">MTHFR 677 TT genotype<sup>a</sup></td><td char="." align="char">51</td><td char="(" align="char">13.0 (7.6&#8211;50.0)</td><td char="." align="char">0.13</td></tr>
###xml 1051 1075 1048 1072 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">None of these conditions</td>
###xml 1075 1078 1072 1075 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">392</td>
###xml 1078 1093 1075 1090 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">12.4 (2.9&#8211;48.3)</td>
###xml 1093 1093 1090 1090 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1051 1093 1048 1090 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">None of these conditions</td><td char="." align="char">392</td><td char="(" align="char">12.4 (2.9&#8211;48.3)</td><td align="left"/></tr>
###xml 860 1093 857 1090 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Diabetes mellitus</td><td char="." align="char">13</td><td char="(" align="char">15.4 (11.0&#8211;29.0)</td><td char="." align="char">0.01</td></tr><tr><td align="left">Hypothyreosis</td><td char="." align="char">6</td><td char="(" align="char">10.6 (9.6&#8211;14.4)</td><td char="." align="char">0.23</td></tr><tr><td align="left">Renal dysfunction (S-cystatin C above reference range)<sup>a</sup></td><td char="." align="char">17</td><td char="(" align="char">16.4 (9.4&#8211;29.6)</td><td char="." align="char">0.01</td></tr><tr><td align="left">MTHFR 677 TT genotype<sup>a</sup></td><td char="." align="char">51</td><td char="(" align="char">13.0 (7.6&#8211;50.0)</td><td char="." align="char">0.13</td></tr><tr><td align="left">None of these conditions</td><td char="." align="char">392</td><td char="(" align="char">12.4 (2.9&#8211;48.3)</td><td align="left"/></tr></tbody>
###xml 679 1093 677 1090 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Condition present at baseline</th><th align="left">No. of participants examined</th><th align="left">P-homocysteine, &#956;mol/l, median (min&#8211;max)</th><th align="left"><italic>P</italic> (Mann&#8211;Whitney U-test) when compared to participants with none of these conditions</th></tr></thead><tbody><tr><td align="left">Diabetes mellitus</td><td char="." align="char">13</td><td char="(" align="char">15.4 (11.0&#8211;29.0)</td><td char="." align="char">0.01</td></tr><tr><td align="left">Hypothyreosis</td><td char="." align="char">6</td><td char="(" align="char">10.6 (9.6&#8211;14.4)</td><td char="." align="char">0.23</td></tr><tr><td align="left">Renal dysfunction (S-cystatin C above reference range)<sup>a</sup></td><td char="." align="char">17</td><td char="(" align="char">16.4 (9.4&#8211;29.6)</td><td char="." align="char">0.01</td></tr><tr><td align="left">MTHFR 677 TT genotype<sup>a</sup></td><td char="." align="char">51</td><td char="(" align="char">13.0 (7.6&#8211;50.0)</td><td char="." align="char">0.13</td></tr><tr><td align="left">None of these conditions</td><td char="." align="char">392</td><td char="(" align="char">12.4 (2.9&#8211;48.3)</td><td align="left"/></tr></tbody></table>
###xml 1093 1094 1090 1091 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1093 1158 1090 1155 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="34"><sup>a</sup>In nine samples, Cystatin C or MTHFR 677 could not be determined</p>
###xml 1093 1158 1090 1155 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34"><sup>a</sup>In nine samples, Cystatin C or MTHFR 677 could not be determined</p></table-wrap-foot>
###xml 573 1158 571 1155 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="33">S-Hcy concentrations in participants with condition reportedly associated with hyperhomocysteinemia</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Condition present at baseline</th><th align="left">No. of participants examined</th><th align="left">P-homocysteine, &#956;mol/l, median (min&#8211;max)</th><th align="left"><italic>P</italic> (Mann&#8211;Whitney U-test) when compared to participants with none of these conditions</th></tr></thead><tbody><tr><td align="left">Diabetes mellitus</td><td char="." align="char">13</td><td char="(" align="char">15.4 (11.0&#8211;29.0)</td><td char="." align="char">0.01</td></tr><tr><td align="left">Hypothyreosis</td><td char="." align="char">6</td><td char="(" align="char">10.6 (9.6&#8211;14.4)</td><td char="." align="char">0.23</td></tr><tr><td align="left">Renal dysfunction (S-cystatin C above reference range)<sup>a</sup></td><td char="." align="char">17</td><td char="(" align="char">16.4 (9.4&#8211;29.6)</td><td char="." align="char">0.01</td></tr><tr><td align="left">MTHFR 677 TT genotype<sup>a</sup></td><td char="." align="char">51</td><td char="(" align="char">13.0 (7.6&#8211;50.0)</td><td char="." align="char">0.13</td></tr><tr><td align="left">None of these conditions</td><td char="." align="char">392</td><td char="(" align="char">12.4 (2.9&#8211;48.3)</td><td align="left"/></tr></tbody></table><table-wrap-foot><p textid="34"><sup>a</sup>In nine samples, Cystatin C or MTHFR 677 could not be determined</p></table-wrap-foot></table-wrap>
###xml 1158 1165 1155 1162 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1165 1301 1162 1298 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">S-vitamin B12, S-folate, and S-homocysteine concentrations in relation to histomorphology in the gastric and duodenal mucosa at baseline</p>
###xml 1165 1301 1162 1298 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">S-vitamin B12, S-folate, and S-homocysteine concentrations in relation to histomorphology in the gastric and duodenal mucosa at baseline</p></caption>
###xml 1301 1332 1298 1329 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Gastro-duodenal histomorphology</th>
###xml 1332 1352 1329 1349 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Vitamin B 12, pmol/l</th>
###xml 1352 1366 1349 1363 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Folate, nmol/l</th>
###xml 1366 1387 1363 1383 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Homocysteine, &#956;mol/l</th>
###xml 1301 1387 1298 1383 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">Gastro-duodenal histomorphology</th><th align="left">Vitamin B 12, pmol/l</th><th align="left">Folate, nmol/l</th><th align="left">Homocysteine, &#956;mol/l</th></tr>
###xml 1416 1416 1412 1412 <break xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1387 1417 1383 1413 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Median (min&#8211;max) no. examined<break/>P</th>
###xml 1446 1446 1442 1442 <break xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1417 1448 1413 1444 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Median (min&#8211;max) no. examined<break/> P</th>
###xml 1477 1477 1473 1473 <break xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1448 1479 1444 1475 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Median (min&#8211;max) no. examined<break/> P</th>
###xml 1387 1479 1383 1475 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Median (min&#8211;max) no. examined<break/>P</th><th align="left">Median (min&#8211;max) no. examined<break/> P</th><th align="left">Median (min&#8211;max) no. examined<break/> P</th></tr>
###xml 1301 1479 1298 1475 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">Gastro-duodenal histomorphology</th><th align="left">Vitamin B 12, pmol/l</th><th align="left">Folate, nmol/l</th><th align="left">Homocysteine, &#956;mol/l</th></tr><tr><th align="left">Median (min&#8211;max) no. examined<break/>P</th><th align="left">Median (min&#8211;max) no. examined<break/> P</th><th align="left">Median (min&#8211;max) no. examined<break/> P</th></tr></thead>
###xml 1509 1517 1505 1513 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.pylori</italic>
###xml 1479 1527 1475 1523 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3">Normal gastric mucosa without <italic>H.pylori</italic> infection</td>
###xml 1527 1540 1523 1536 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">266 (118&#8211;663)</td>
###xml 1540 1554 1536 1550 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9.9 (2.1&#8211;35.2)</td>
###xml 1554 1569 1550 1565 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12.2 (2.9&#8211;33.1)</td>
###xml 1479 1569 1475 1565 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="3">Normal gastric mucosa without <italic>H.pylori</italic> infection</td><td align="left">266 (118&#8211;663)</td><td align="left">9.9 (2.1&#8211;35.2)</td><td align="left">12.2 (2.9&#8211;33.1)</td></tr>
###xml 1569 1572 1565 1568 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">220</td>
###xml 1572 1575 1568 1571 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">215</td>
###xml 1575 1578 1571 1574 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">242</td>
###xml 1569 1578 1565 1574 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">220</td><td align="left">215</td><td align="left">242</td></tr>
###xml 1578 1579 1574 1575 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1579 1580 1575 1576 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1580 1581 1576 1577 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1578 1581 1574 1577 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr>
###xml 1581 1590 1577 1586 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 1581 1668 1577 1664 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3"><italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td>
###xml 1668 1680 1664 1676 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">282 (98&#8211;789)</td>
###xml 1680 1694 1676 1690 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9.0 (3.1&#8211;36.3)</td>
###xml 1694 1709 1690 1705 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">13.1 (4.8&#8211;35.7)</td>
###xml 1581 1709 1577 1705 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="3"><italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td><td align="left">282 (98&#8211;789)</td><td align="left">9.0 (3.1&#8211;36.3)</td><td align="left">13.1 (4.8&#8211;35.7)</td></tr>
###xml 1709 1712 1705 1708 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">179</td>
###xml 1712 1715 1708 1711 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">175</td>
###xml 1715 1718 1711 1714 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">190</td>
###xml 1709 1718 1705 1714 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">179</td><td align="left">175</td><td align="left">190</td></tr>
###xml 1722 1723 1718 1719 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1718 1723 1714 1719 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.72<sup>a</sup></td>
###xml 1727 1728 1723 1724 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1723 1728 1719 1724 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.21<sup>a</sup></td>
###xml 1732 1733 1728 1729 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1728 1733 1724 1729 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.06<sup>a</sup></td>
###xml 1718 1733 1714 1729 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">0.72<sup>a</sup></td><td align="left">0.21<sup>a</sup></td><td align="left">0.06<sup>a</sup></td></tr>
###xml 1737 1746 1733 1742 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 1733 1824 1729 1820 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3">Non-<italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td>
###xml 1824 1837 1820 1833 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">281 (161&#8211;575)</td>
###xml 1837 1852 1833 1848 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12.1 (5.1&#8211;30.0)</td>
###xml 1852 1867 1848 1863 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12.0 (8.7&#8211;21.2)</td>
###xml 1733 1867 1729 1863 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="3">Non-<italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td><td align="left">281 (161&#8211;575)</td><td align="left">12.1 (5.1&#8211;30.0)</td><td align="left">12.0 (8.7&#8211;21.2)</td></tr>
###xml 1867 1869 1863 1865 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">27</td>
###xml 1869 1871 1865 1867 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">24</td>
###xml 1871 1873 1867 1869 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">27</td>
###xml 1867 1873 1863 1869 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">27</td><td align="left">24</td><td align="left">27</td></tr>
###xml 1877 1878 1873 1874 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1873 1878 1869 1874 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.86<sup>a</sup></td>
###xml 1882 1883 1878 1879 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1878 1883 1874 1879 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.08<sup>a</sup></td>
###xml 1887 1888 1883 1884 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1883 1888 1879 1884 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.50<sup>a</sup></td>
###xml 1873 1888 1869 1884 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">0.86<sup>a</sup></td><td align="left">0.08<sup>a</sup></td><td align="left">0.50<sup>a</sup></td></tr>
###xml 1956 1965 1952 1961 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 1888 1975 1884 1971 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3">Chronic gastritis with atrophy of the corpus mucosa with or without <italic>H.&#160;pylori</italic> infection</td>
###xml 1975 1988 1971 1984 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">269 (107&#8211;497)</td>
###xml 1988 2002 1984 1998 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9.6 (4.0&#8211;24.2)</td>
###xml 2002 2018 1998 2014 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">20.1 (10.2&#8211;50.0)</td>
###xml 1888 2018 1884 2014 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="3">Chronic gastritis with atrophy of the corpus mucosa with or without <italic>H.&#160;pylori</italic> infection</td><td align="left">269 (107&#8211;497)</td><td align="left">9.6 (4.0&#8211;24.2)</td><td align="left">20.1 (10.2&#8211;50.0)</td></tr>
###xml 2018 2020 2014 2016 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15</td>
###xml 2020 2022 2016 2018 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">19</td>
###xml 2022 2024 2018 2020 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">20</td>
###xml 2018 2024 2014 2020 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">15</td><td align="left">19</td><td align="left">20</td></tr>
###xml 2028 2029 2024 2025 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2024 2029 2020 2025 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.14<sup>a</sup></td>
###xml 2033 2034 2029 2030 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2029 2034 2025 2030 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.61<sup>a</sup></td>
###xml 2040 2041 2036 2037 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2034 2041 2030 2037 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;0.001<sup>a</sup></td>
###xml 2024 2041 2020 2037 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">0.14<sup>a</sup></td><td align="left">0.61<sup>a</sup></td><td align="left">&lt;0.001<sup>a</sup></td></tr>
###xml 2041 2094 2037 2090 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3">No significant villous atrophy of the duodenal mucosa</td>
###xml 2094 2106 2090 2102 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">269 (98&#8211;789)</td>
###xml 2106 2120 2102 2116 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9.6 (3.1&#8211;36.3)</td>
###xml 2120 2135 2116 2131 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12.7 (2.9&#8211;50.0)</td>
###xml 2041 2135 2037 2131 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="3">No significant villous atrophy of the duodenal mucosa</td><td align="left">269 (98&#8211;789)</td><td align="left">9.6 (3.1&#8211;36.3)</td><td align="left">12.7 (2.9&#8211;50.0)</td></tr>
###xml 2135 2138 2131 2134 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">430</td>
###xml 2138 2141 2134 2137 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">422</td>
###xml 2141 2144 2137 2140 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">467</td>
###xml 2135 2144 2131 2140 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">430</td><td align="left">422</td><td align="left">467</td></tr>
###xml 2144 2145 2140 2141 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 2145 2146 2141 2142 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 2146 2147 2142 2143 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 2144 2147 2140 2143 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr>
###xml 2147 2213 2143 2209 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3">Villous atrophy of the duodenal mucosa (Alexander grade III to IV)</td>
###xml 2213 2226 2209 2222 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">319 (224&#8211;603)</td>
###xml 2226 2240 2222 2236 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6.1 (2.1&#8211;12.8)</td>
###xml 2240 2255 2236 2251 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">13.9 (8.5&#8211;33.1)</td>
###xml 2147 2255 2143 2251 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" rowspan="3">Villous atrophy of the duodenal mucosa (Alexander grade III to IV)</td><td align="left">319 (224&#8211;603)</td><td align="left">6.1 (2.1&#8211;12.8)</td><td align="left">13.9 (8.5&#8211;33.1)</td></tr>
###xml 2255 2256 2251 2252 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8</td>
###xml 2256 2257 2252 2253 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8</td>
###xml 2257 2258 2253 2254 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9</td>
###xml 2255 2258 2251 2254 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">8</td><td align="left">8</td><td align="left">9</td></tr>
###xml 2262 2263 2258 2259 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2258 2263 2254 2259 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.16<sup>b</sup></td>
###xml 2267 2268 2263 2264 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2263 2268 2259 2264 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.02<sup>b</sup></td>
###xml 2272 2273 2268 2269 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2268 2273 2264 2269 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.47<sup>b</sup></td>
###xml 2258 2273 2254 2269 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">0.16<sup>b</sup></td><td align="left">0.02<sup>b</sup></td><td align="left">0.47<sup>b</sup></td></tr>
###xml 1479 2273 1475 2269 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" rowspan="3">Normal gastric mucosa without <italic>H.pylori</italic> infection</td><td align="left">266 (118&#8211;663)</td><td align="left">9.9 (2.1&#8211;35.2)</td><td align="left">12.2 (2.9&#8211;33.1)</td></tr><tr><td align="left">220</td><td align="left">215</td><td align="left">242</td></tr><tr><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left" rowspan="3"><italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td><td align="left">282 (98&#8211;789)</td><td align="left">9.0 (3.1&#8211;36.3)</td><td align="left">13.1 (4.8&#8211;35.7)</td></tr><tr><td align="left">179</td><td align="left">175</td><td align="left">190</td></tr><tr><td align="left">0.72<sup>a</sup></td><td align="left">0.21<sup>a</sup></td><td align="left">0.06<sup>a</sup></td></tr><tr><td align="left" rowspan="3">Non-<italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td><td align="left">281 (161&#8211;575)</td><td align="left">12.1 (5.1&#8211;30.0)</td><td align="left">12.0 (8.7&#8211;21.2)</td></tr><tr><td align="left">27</td><td align="left">24</td><td align="left">27</td></tr><tr><td align="left">0.86<sup>a</sup></td><td align="left">0.08<sup>a</sup></td><td align="left">0.50<sup>a</sup></td></tr><tr><td align="left" rowspan="3">Chronic gastritis with atrophy of the corpus mucosa with or without <italic>H.&#160;pylori</italic> infection</td><td align="left">269 (107&#8211;497)</td><td align="left">9.6 (4.0&#8211;24.2)</td><td align="left">20.1 (10.2&#8211;50.0)</td></tr><tr><td align="left">15</td><td align="left">19</td><td align="left">20</td></tr><tr><td align="left">0.14<sup>a</sup></td><td align="left">0.61<sup>a</sup></td><td align="left">&lt;0.001<sup>a</sup></td></tr><tr><td align="left" rowspan="3">No significant villous atrophy of the duodenal mucosa</td><td align="left">269 (98&#8211;789)</td><td align="left">9.6 (3.1&#8211;36.3)</td><td align="left">12.7 (2.9&#8211;50.0)</td></tr><tr><td align="left">430</td><td align="left">422</td><td align="left">467</td></tr><tr><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left" rowspan="3">Villous atrophy of the duodenal mucosa (Alexander grade III to IV)</td><td align="left">319 (224&#8211;603)</td><td align="left">6.1 (2.1&#8211;12.8)</td><td align="left">13.9 (8.5&#8211;33.1)</td></tr><tr><td align="left">8</td><td align="left">8</td><td align="left">9</td></tr><tr><td align="left">0.16<sup>b</sup></td><td align="left">0.02<sup>b</sup></td><td align="left">0.47<sup>b</sup></td></tr></tbody>
###xml 1301 2273 1298 2269 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Gastro-duodenal histomorphology</th><th align="left">Vitamin B 12, pmol/l</th><th align="left">Folate, nmol/l</th><th align="left">Homocysteine, &#956;mol/l</th></tr><tr><th align="left">Median (min&#8211;max) no. examined<break/>P</th><th align="left">Median (min&#8211;max) no. examined<break/> P</th><th align="left">Median (min&#8211;max) no. examined<break/> P</th></tr></thead><tbody><tr><td align="left" rowspan="3">Normal gastric mucosa without <italic>H.pylori</italic> infection</td><td align="left">266 (118&#8211;663)</td><td align="left">9.9 (2.1&#8211;35.2)</td><td align="left">12.2 (2.9&#8211;33.1)</td></tr><tr><td align="left">220</td><td align="left">215</td><td align="left">242</td></tr><tr><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left" rowspan="3"><italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td><td align="left">282 (98&#8211;789)</td><td align="left">9.0 (3.1&#8211;36.3)</td><td align="left">13.1 (4.8&#8211;35.7)</td></tr><tr><td align="left">179</td><td align="left">175</td><td align="left">190</td></tr><tr><td align="left">0.72<sup>a</sup></td><td align="left">0.21<sup>a</sup></td><td align="left">0.06<sup>a</sup></td></tr><tr><td align="left" rowspan="3">Non-<italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td><td align="left">281 (161&#8211;575)</td><td align="left">12.1 (5.1&#8211;30.0)</td><td align="left">12.0 (8.7&#8211;21.2)</td></tr><tr><td align="left">27</td><td align="left">24</td><td align="left">27</td></tr><tr><td align="left">0.86<sup>a</sup></td><td align="left">0.08<sup>a</sup></td><td align="left">0.50<sup>a</sup></td></tr><tr><td align="left" rowspan="3">Chronic gastritis with atrophy of the corpus mucosa with or without <italic>H.&#160;pylori</italic> infection</td><td align="left">269 (107&#8211;497)</td><td align="left">9.6 (4.0&#8211;24.2)</td><td align="left">20.1 (10.2&#8211;50.0)</td></tr><tr><td align="left">15</td><td align="left">19</td><td align="left">20</td></tr><tr><td align="left">0.14<sup>a</sup></td><td align="left">0.61<sup>a</sup></td><td align="left">&lt;0.001<sup>a</sup></td></tr><tr><td align="left" rowspan="3">No significant villous atrophy of the duodenal mucosa</td><td align="left">269 (98&#8211;789)</td><td align="left">9.6 (3.1&#8211;36.3)</td><td align="left">12.7 (2.9&#8211;50.0)</td></tr><tr><td align="left">430</td><td align="left">422</td><td align="left">467</td></tr><tr><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left" rowspan="3">Villous atrophy of the duodenal mucosa (Alexander grade III to IV)</td><td align="left">319 (224&#8211;603)</td><td align="left">6.1 (2.1&#8211;12.8)</td><td align="left">13.9 (8.5&#8211;33.1)</td></tr><tr><td align="left">8</td><td align="left">8</td><td align="left">9</td></tr><tr><td align="left">0.16<sup>b</sup></td><td align="left">0.02<sup>b</sup></td><td align="left">0.47<sup>b</sup></td></tr></tbody></table>
###xml 2273 2274 2269 2270 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2274 2275 2270 2271 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2273 2367 2269 2363 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><sup>a</sup><italic>P</italic>-value from the Mann&#8211;Whitney U-test when compared to participants with normal gastric mucosa</p>
###xml 2367 2368 2363 2364 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2368 2369 2364 2365 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2367 2489 2363 2485 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><sup>b</sup><italic>P</italic>-value from the Mann&#8211;Whitney U-test when compared to participants with mild or no villous atrophy of the duodenal mucosa</p>
###xml 2273 2489 2269 2485 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36"><sup>a</sup><italic>P</italic>-value from the Mann&#8211;Whitney U-test when compared to participants with normal gastric mucosa</p><p textid="37"><sup>b</sup><italic>P</italic>-value from the Mann&#8211;Whitney U-test when compared to participants with mild or no villous atrophy of the duodenal mucosa</p></table-wrap-foot>
###xml 1158 2489 1155 2485 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="35">S-vitamin B12, S-folate, and S-homocysteine concentrations in relation to histomorphology in the gastric and duodenal mucosa at baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Gastro-duodenal histomorphology</th><th align="left">Vitamin B 12, pmol/l</th><th align="left">Folate, nmol/l</th><th align="left">Homocysteine, &#956;mol/l</th></tr><tr><th align="left">Median (min&#8211;max) no. examined<break/>P</th><th align="left">Median (min&#8211;max) no. examined<break/> P</th><th align="left">Median (min&#8211;max) no. examined<break/> P</th></tr></thead><tbody><tr><td align="left" rowspan="3">Normal gastric mucosa without <italic>H.pylori</italic> infection</td><td align="left">266 (118&#8211;663)</td><td align="left">9.9 (2.1&#8211;35.2)</td><td align="left">12.2 (2.9&#8211;33.1)</td></tr><tr><td align="left">220</td><td align="left">215</td><td align="left">242</td></tr><tr><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left" rowspan="3"><italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td><td align="left">282 (98&#8211;789)</td><td align="left">9.0 (3.1&#8211;36.3)</td><td align="left">13.1 (4.8&#8211;35.7)</td></tr><tr><td align="left">179</td><td align="left">175</td><td align="left">190</td></tr><tr><td align="left">0.72<sup>a</sup></td><td align="left">0.21<sup>a</sup></td><td align="left">0.06<sup>a</sup></td></tr><tr><td align="left" rowspan="3">Non-<italic>H.&#160;pylori</italic>-associated chronic gastritis without significant atrophy of the corpus mucosa</td><td align="left">281 (161&#8211;575)</td><td align="left">12.1 (5.1&#8211;30.0)</td><td align="left">12.0 (8.7&#8211;21.2)</td></tr><tr><td align="left">27</td><td align="left">24</td><td align="left">27</td></tr><tr><td align="left">0.86<sup>a</sup></td><td align="left">0.08<sup>a</sup></td><td align="left">0.50<sup>a</sup></td></tr><tr><td align="left" rowspan="3">Chronic gastritis with atrophy of the corpus mucosa with or without <italic>H.&#160;pylori</italic> infection</td><td align="left">269 (107&#8211;497)</td><td align="left">9.6 (4.0&#8211;24.2)</td><td align="left">20.1 (10.2&#8211;50.0)</td></tr><tr><td align="left">15</td><td align="left">19</td><td align="left">20</td></tr><tr><td align="left">0.14<sup>a</sup></td><td align="left">0.61<sup>a</sup></td><td align="left">&lt;0.001<sup>a</sup></td></tr><tr><td align="left" rowspan="3">No significant villous atrophy of the duodenal mucosa</td><td align="left">269 (98&#8211;789)</td><td align="left">9.6 (3.1&#8211;36.3)</td><td align="left">12.7 (2.9&#8211;50.0)</td></tr><tr><td align="left">430</td><td align="left">422</td><td align="left">467</td></tr><tr><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left" rowspan="3">Villous atrophy of the duodenal mucosa (Alexander grade III to IV)</td><td align="left">319 (224&#8211;603)</td><td align="left">6.1 (2.1&#8211;12.8)</td><td align="left">13.9 (8.5&#8211;33.1)</td></tr><tr><td align="left">8</td><td align="left">8</td><td align="left">9</td></tr><tr><td align="left">0.16<sup>b</sup></td><td align="left">0.02<sup>b</sup></td><td align="left">0.47<sup>b</sup></td></tr></tbody></table><table-wrap-foot><p textid="36"><sup>a</sup><italic>P</italic>-value from the Mann&#8211;Whitney U-test when compared to participants with normal gastric mucosa</p><p textid="37"><sup>b</sup><italic>P</italic>-value from the Mann&#8211;Whitney U-test when compared to participants with mild or no villous atrophy of the duodenal mucosa</p></table-wrap-foot></table-wrap>
###xml 38 50 <span type="species:ncbi:9606">participants</span>
###xml 171 183 <span type="species:ncbi:9606">participants</span>
###xml 231 240 <span type="species:ncbi:210">H. pylori</span>
###xml 291 303 <span type="species:ncbi:9606">participants</span>
###xml 450 462 <span type="species:ncbi:9606">participants</span>
###xml 604 616 <span type="species:ncbi:9606">participants</span>
###xml 715 727 <span type="species:ncbi:9606">participants</span>
###xml 818 830 <span type="species:ncbi:9606">participants</span>
###xml 1509 1517 <span type="species:ncbi:210">H.pylori</span>
###xml 1581 1590 <span type="species:ncbi:210">H. pylori</span>
###xml 1737 1746 <span type="species:ncbi:210">H. pylori</span>
###xml 1956 1965 <span type="species:ncbi:210">H. pylori</span>
###xml 2328 2340 <span type="species:ncbi:9606">participants</span>
###xml 2422 2434 <span type="species:ncbi:9606">participants</span>
S-Hcy concentrations were elevated in participants with DM and in those with elevated S-cystatin C (Table 1). Table 2 shows that S-Hcy concentrations were increased among participants with atrophic gastritis, but not in those with H. pylori-associated gastritis without atrophy. Considering participants with subnormal PGI/PGII, indicative of atrophy of the gastric corpus mucosa, results were similar with median S-Hcy 17.5 (9.8-50.0) mumol/l among participants with subnormal PGI/PGII and 12.5 (2.9-33.1) mumol/l among those with PGI/PGII within normal range (P < 0.001).Table 1S-Hcy concentrations in participants with condition reportedly associated with hyperhomocysteinemiaCondition present at baselineNo. of participants examinedP-homocysteine, mumol/l, median (min-max)P (Mann-Whitney U-test) when compared to participants with none of these conditionsDiabetes mellitus1315.4 (11.0-29.0)0.01Hypothyreosis610.6 (9.6-14.4)0.23Renal dysfunction (S-cystatin C above reference range)a1716.4 (9.4-29.6)0.01MTHFR 677 TT genotypea5113.0 (7.6-50.0)0.13None of these conditions39212.4 (2.9-48.3)aIn nine samples, Cystatin C or MTHFR 677 could not be determinedTable 2S-vitamin B12, S-folate, and S-homocysteine concentrations in relation to histomorphology in the gastric and duodenal mucosa at baselineGastro-duodenal histomorphologyVitamin B 12, pmol/lFolate, nmol/lHomocysteine, mumol/lMedian (min-max) no. examinedPMedian (min-max) no. examined PMedian (min-max) no. examined PNormal gastric mucosa without H.pylori infection266 (118-663)9.9 (2.1-35.2)12.2 (2.9-33.1)220215242---H. pylori-associated chronic gastritis without significant atrophy of the corpus mucosa282 (98-789)9.0 (3.1-36.3)13.1 (4.8-35.7)1791751900.72a0.21a0.06aNon-H. pylori-associated chronic gastritis without significant atrophy of the corpus mucosa281 (161-575)12.1 (5.1-30.0)12.0 (8.7-21.2)2724270.86a0.08a0.50aChronic gastritis with atrophy of the corpus mucosa with or without H. pylori infection269 (107-497)9.6 (4.0-24.2)20.1 (10.2-50.0)1519200.14a0.61a<0.001aNo significant villous atrophy of the duodenal mucosa269 (98-789)9.6 (3.1-36.3)12.7 (2.9-50.0)430422467---Villous atrophy of the duodenal mucosa (Alexander grade III to IV)319 (224-603)6.1 (2.1-12.8)13.9 (8.5-33.1)8890.16b0.02b0.47baP-value from the Mann-Whitney U-test when compared to participants with normal gastric mucosabP-value from the Mann-Whitney U-test when compared to participants with mild or no villous atrophy of the duodenal mucosa
###end p 32
###begin p 33
###xml 24 36 <span type="species:ncbi:9606">participants</span>
S-Hcy concentrations in participants with condition reportedly associated with hyperhomocysteinemia
###end p 33
###begin p 34
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aIn nine samples, Cystatin C or MTHFR 677 could not be determined
###end p 34
###begin p 35
S-vitamin B12, S-folate, and S-homocysteine concentrations in relation to histomorphology in the gastric and duodenal mucosa at baseline
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 2 1 2 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 55 67 <span type="species:ncbi:9606">participants</span>
aP-value from the Mann-Whitney U-test when compared to participants with normal gastric mucosa
###end p 36
###begin p 37
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1 2 1 2 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 55 67 <span type="species:ncbi:9606">participants</span>
bP-value from the Mann-Whitney U-test when compared to participants with mild or no villous atrophy of the duodenal mucosa
###end p 37
###begin p 38
###xml 50 62 <span type="species:ncbi:9606">participants</span>
S-Hcy levels did not differ significantly between participants with the MTHFR 677 TT genotype (13.0 (7.6-50.0) mumol/l) and those with the CT (12.7 (4.8-33.1) mumol/l) or CC genotype (12.7 (2.9-48.3) mumol/l), nor was there any relation between S-Hcy levels and the presence of the T allele (12.8 (4.8-50.0) mumol/l).
###end p 38
###begin p 39
###xml 20 21 20 21 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 261 262 261 262 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 391 392 391 392 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 408 417 408 417 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 566 573 566 573 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 573 688 573 688 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="40">General linear model estimates of factors with putative impact on S-homocysteine concentration (dependent variable)</p>
###xml 573 688 573 688 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40">General linear model estimates of factors with putative impact on S-homocysteine concentration (dependent variable)</p></caption>
###xml 688 708 688 708 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Independent variable</th>
###xml 708 719 708 719 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Coefficient</th>
###xml 719 752 719 752 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">95% confidence interval (min&#8211;max)</th>
###xml 752 753 752 753 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 752 753 752 753 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic></th>
###xml 688 753 688 753 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Independent variable</th><th align="left">Coefficient</th><th align="left">95% confidence interval (min&#8211;max)</th><th align="left"><italic>P</italic></th></tr>
###xml 688 753 688 753 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Independent variable</th><th align="left">Coefficient</th><th align="left">95% confidence interval (min&#8211;max)</th><th align="left"><italic>P</italic></th></tr></thead>
###xml 753 764 753 764 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male gender</td>
###xml 764 768 764 768 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.57</td>
###xml 768 777 768 777 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.65&#8211;2.49</td>
###xml 777 782 777 782 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.001</td>
###xml 753 782 753 782 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Male gender</td><td char="." align="char">1.57</td><td char="." align="char">0.65&#8211;2.49</td><td char="." align="char">0.001</td></tr>
###xml 782 785 782 785 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age</td>
###xml 785 789 785 789 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.08</td>
###xml 789 797 789 797 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0&#8211;0.13</td>
###xml 797 802 797 802 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.001</td>
###xml 782 802 782 802 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Age</td><td char="." align="char">0.08</td><td char="." align="char">0.0&#8211;0.13</td><td char="." align="char">0.001</td></tr>
###xml 802 805 802 805 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMI</td>
###xml 805 810 805 810 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.03</td>
###xml 810 820 810 820 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.17&#8211;0.10</td>
###xml 820 824 820 824 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.62</td>
###xml 802 824 802 824 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMI</td><td char="." align="char">&#8722;0.03</td><td char="." align="char">&#8722;0.17&#8211;0.10</td><td char="." align="char">0.62</td></tr>
###xml 824 841 824 841 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Diabetes mellitus</td>
###xml 841 845 841 845 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.52</td>
###xml 845 855 845 855 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.42&#8211;5.46</td>
###xml 855 859 855 859 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.09</td>
###xml 824 859 824 859 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Diabetes mellitus</td><td char="." align="char">2.52</td><td char="." align="char">&#8722;0.42&#8211;5.46</td><td char="." align="char">0.09</td></tr>
###xml 859 872 859 872 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hypothyreosis</td>
###xml 872 876 872 876 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.84</td>
###xml 876 886 876 886 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;2.92&#8211;4.60</td>
###xml 886 890 886 890 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.66</td>
###xml 859 890 859 890 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Hypothyreosis</td><td char="." align="char">0.84</td><td char="." align="char">&#8722;2.92&#8211;4.60</td><td char="." align="char">0.66</td></tr>
###xml 890 902 890 902 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">S-cystatin C</td>
###xml 902 906 902 906 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.71</td>
###xml 906 915 906 915 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.26&#8211;4.15</td>
###xml 915 921 915 921 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.001</td>
###xml 890 921 890 921 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">S-cystatin C</td><td char="." align="char">2.71</td><td char="." align="char">1.26&#8211;4.15</td><td char="." align="char">&lt;0.001</td></tr>
###xml 921 934 921 934 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">S-vitamin B12</td>
###xml 934 939 934 939 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.01</td>
###xml 939 949 939 949 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.01&#8211;0.00</td>
###xml 949 955 949 955 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.001</td>
###xml 921 955 921 955 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">S-vitamin B12</td><td char="." align="char">&#8722;0.01</td><td char="." align="char">&#8722;0.01&#8211;0.00</td><td char="." align="char">&lt;0.001</td></tr>
###xml 955 963 955 963 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">S-folate</td>
###xml 963 968 963 968 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.16</td>
###xml 968 979 968 979 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.24&#8211;&#8722;0.08</td>
###xml 979 985 979 985 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.001</td>
###xml 955 985 955 985 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">S-folate</td><td char="." align="char">&#8722;0.16</td><td char="." align="char">&#8722;0.24&#8211;&#8722;0.08</td><td char="." align="char">&lt;0.001</td></tr>
###xml 985 1006 985 1006 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">MTHFR 677 TT genotype</td>
###xml 1006 1011 1006 1011 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.645</td>
###xml 1011 1020 1011 1020 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.27&#8211;3.02</td>
###xml 1020 1024 1020 1024 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 985 1024 985 1024 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">MTHFR 677 TT genotype</td><td char="." align="char">1.645</td><td char="." align="char">0.27&#8211;3.02</td><td char="." align="char">0.02</td></tr>
###xml 1024 1060 1024 1060 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Atrophy of the gastric corpus mucosa</td>
###xml 1060 1064 1060 1064 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.62</td>
###xml 1064 1073 1064 1073 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.00&#8211;7.24</td>
###xml 1073 1078 1073 1078 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.001</td>
###xml 1024 1078 1024 1078 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Atrophy of the gastric corpus mucosa</td><td char="." align="char">4.62</td><td char="." align="char">2.00&#8211;7.24</td><td char="." align="char">0.001</td></tr>
###xml 1078 1133 1078 1133 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Atrophy of the duodenal mucosa (Alexander grade III&#8211;IV)</td>
###xml 1133 1137 1133 1137 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.50</td>
###xml 1137 1147 1137 1147 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.75&#8211;5.76</td>
###xml 1147 1151 1147 1151 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13</td>
###xml 1078 1151 1078 1151 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Atrophy of the duodenal mucosa (Alexander grade III&#8211;IV)</td><td char="." align="char">2.50</td><td char="." align="char">&#8722;0.75&#8211;5.76</td><td char="." align="char">0.13</td></tr>
###xml 753 1151 753 1151 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Male gender</td><td char="." align="char">1.57</td><td char="." align="char">0.65&#8211;2.49</td><td char="." align="char">0.001</td></tr><tr><td align="left">Age</td><td char="." align="char">0.08</td><td char="." align="char">0.0&#8211;0.13</td><td char="." align="char">0.001</td></tr><tr><td align="left">BMI</td><td char="." align="char">&#8722;0.03</td><td char="." align="char">&#8722;0.17&#8211;0.10</td><td char="." align="char">0.62</td></tr><tr><td align="left">Diabetes mellitus</td><td char="." align="char">2.52</td><td char="." align="char">&#8722;0.42&#8211;5.46</td><td char="." align="char">0.09</td></tr><tr><td align="left">Hypothyreosis</td><td char="." align="char">0.84</td><td char="." align="char">&#8722;2.92&#8211;4.60</td><td char="." align="char">0.66</td></tr><tr><td align="left">S-cystatin C</td><td char="." align="char">2.71</td><td char="." align="char">1.26&#8211;4.15</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">S-vitamin B12</td><td char="." align="char">&#8722;0.01</td><td char="." align="char">&#8722;0.01&#8211;0.00</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">S-folate</td><td char="." align="char">&#8722;0.16</td><td char="." align="char">&#8722;0.24&#8211;&#8722;0.08</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">MTHFR 677 TT genotype</td><td char="." align="char">1.645</td><td char="." align="char">0.27&#8211;3.02</td><td char="." align="char">0.02</td></tr><tr><td align="left">Atrophy of the gastric corpus mucosa</td><td char="." align="char">4.62</td><td char="." align="char">2.00&#8211;7.24</td><td char="." align="char">0.001</td></tr><tr><td align="left">Atrophy of the duodenal mucosa (Alexander grade III&#8211;IV)</td><td char="." align="char">2.50</td><td char="." align="char">&#8722;0.75&#8211;5.76</td><td char="." align="char">0.13</td></tr></tbody>
###xml 688 1151 688 1151 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Independent variable</th><th align="left">Coefficient</th><th align="left">95% confidence interval (min&#8211;max)</th><th align="left"><italic>P</italic></th></tr></thead><tbody><tr><td align="left">Male gender</td><td char="." align="char">1.57</td><td char="." align="char">0.65&#8211;2.49</td><td char="." align="char">0.001</td></tr><tr><td align="left">Age</td><td char="." align="char">0.08</td><td char="." align="char">0.0&#8211;0.13</td><td char="." align="char">0.001</td></tr><tr><td align="left">BMI</td><td char="." align="char">&#8722;0.03</td><td char="." align="char">&#8722;0.17&#8211;0.10</td><td char="." align="char">0.62</td></tr><tr><td align="left">Diabetes mellitus</td><td char="." align="char">2.52</td><td char="." align="char">&#8722;0.42&#8211;5.46</td><td char="." align="char">0.09</td></tr><tr><td align="left">Hypothyreosis</td><td char="." align="char">0.84</td><td char="." align="char">&#8722;2.92&#8211;4.60</td><td char="." align="char">0.66</td></tr><tr><td align="left">S-cystatin C</td><td char="." align="char">2.71</td><td char="." align="char">1.26&#8211;4.15</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">S-vitamin B12</td><td char="." align="char">&#8722;0.01</td><td char="." align="char">&#8722;0.01&#8211;0.00</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">S-folate</td><td char="." align="char">&#8722;0.16</td><td char="." align="char">&#8722;0.24&#8211;&#8722;0.08</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">MTHFR 677 TT genotype</td><td char="." align="char">1.645</td><td char="." align="char">0.27&#8211;3.02</td><td char="." align="char">0.02</td></tr><tr><td align="left">Atrophy of the gastric corpus mucosa</td><td char="." align="char">4.62</td><td char="." align="char">2.00&#8211;7.24</td><td char="." align="char">0.001</td></tr><tr><td align="left">Atrophy of the duodenal mucosa (Alexander grade III&#8211;IV)</td><td char="." align="char">2.50</td><td char="." align="char">&#8722;0.75&#8211;5.76</td><td char="." align="char">0.13</td></tr></tbody></table>
###xml 566 1151 566 1151 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="40">General linear model estimates of factors with putative impact on S-homocysteine concentration (dependent variable)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Independent variable</th><th align="left">Coefficient</th><th align="left">95% confidence interval (min&#8211;max)</th><th align="left"><italic>P</italic></th></tr></thead><tbody><tr><td align="left">Male gender</td><td char="." align="char">1.57</td><td char="." align="char">0.65&#8211;2.49</td><td char="." align="char">0.001</td></tr><tr><td align="left">Age</td><td char="." align="char">0.08</td><td char="." align="char">0.0&#8211;0.13</td><td char="." align="char">0.001</td></tr><tr><td align="left">BMI</td><td char="." align="char">&#8722;0.03</td><td char="." align="char">&#8722;0.17&#8211;0.10</td><td char="." align="char">0.62</td></tr><tr><td align="left">Diabetes mellitus</td><td char="." align="char">2.52</td><td char="." align="char">&#8722;0.42&#8211;5.46</td><td char="." align="char">0.09</td></tr><tr><td align="left">Hypothyreosis</td><td char="." align="char">0.84</td><td char="." align="char">&#8722;2.92&#8211;4.60</td><td char="." align="char">0.66</td></tr><tr><td align="left">S-cystatin C</td><td char="." align="char">2.71</td><td char="." align="char">1.26&#8211;4.15</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">S-vitamin B12</td><td char="." align="char">&#8722;0.01</td><td char="." align="char">&#8722;0.01&#8211;0.00</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">S-folate</td><td char="." align="char">&#8722;0.16</td><td char="." align="char">&#8722;0.24&#8211;&#8722;0.08</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">MTHFR 677 TT genotype</td><td char="." align="char">1.645</td><td char="." align="char">0.27&#8211;3.02</td><td char="." align="char">0.02</td></tr><tr><td align="left">Atrophy of the gastric corpus mucosa</td><td char="." align="char">4.62</td><td char="." align="char">2.00&#8211;7.24</td><td char="." align="char">0.001</td></tr><tr><td align="left">Atrophy of the duodenal mucosa (Alexander grade III&#8211;IV)</td><td char="." align="char">2.50</td><td char="." align="char">&#8722;0.75&#8211;5.76</td><td char="." align="char">0.13</td></tr></tbody></table></table-wrap>
###xml 408 417 <span type="species:ncbi:210">H. pylori</span>
GLM analysis (Table 3) showed that S-Hcy concentrations were related to gender, age, S-cystatin C, S-vitamin B12, S-folate, MTHFR 677 TT genotype, and the occurrence of atrophic gastritis. Substituting the morphological diagnosis of atrophic gastritis in Table 3 for subnormal PGI/PGII yielded similar results overall and the coefficient for subnormal PGI/PGII was 5.96 (95% c.i. 3.35-8.56, P < 0.001). When H. pylori-associated chronic gastritis without significant atrophy of the corpus mucosa was included in the model, no significant relation to S-Hcy was shown.Table 3General linear model estimates of factors with putative impact on S-homocysteine concentration (dependent variable)Independent variableCoefficient95% confidence interval (min-max)PMale gender1.570.65-2.490.001Age0.080.0-0.130.001BMI-0.03-0.17-0.100.62Diabetes mellitus2.52-0.42-5.460.09Hypothyreosis0.84-2.92-4.600.66S-cystatin C2.711.26-4.15<0.001S-vitamin B12-0.01-0.01-0.00<0.001S-folate-0.16-0.24--0.08<0.001MTHFR 677 TT genotype1.6450.27-3.020.02Atrophy of the gastric corpus mucosa4.622.00-7.240.001Atrophy of the duodenal mucosa (Alexander grade III-IV)2.50-0.75-5.760.13
###end p 39
###begin p 40
General linear model estimates of factors with putative impact on S-homocysteine concentration (dependent variable)
###end p 40
###begin p 41
###xml 238 240 238 240 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 260 262 260 262 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 292 293 292 293 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 308 310 308 310 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 351 353 351 353 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 17 29 <span type="species:ncbi:9606">participants</span>
###xml 128 134 <span type="species:ncbi:9606">person</span>
###xml 394 406 <span type="species:ncbi:9606">participants</span>
###xml 437 443 <span type="species:ncbi:9606">person</span>
###xml 466 478 <span type="species:ncbi:9606">participants</span>
###xml 707 719 <span type="species:ncbi:9606">participants</span>
At baseline, 438 participants had no history of any cardiovascular disease. They were followed-up for 129 (9-178) months (4,796 person years), during which 101 were diagnosed with cardiovascular disease. These were myocardial infarction [28], angina pectoris [17], abdominal aortic aneurysm [6], TIA/stroke [18], and cardiac arrhythmia/heart failure [32]. The median follow-up time for all 488 participants was 128 (1-180) months (5,262 person years). Among all 488 participants, 25 developed dementia. In six, the form of dementia was classified as Alzheimer's disease, in three as vascular dementia, in six as mixed dementia, and in ten it was not classified. Mild cognitive impairment (diagnosed in five participants) was not defined as dementia.
###end p 41
###begin p 42
###xml 197 198 197 198 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 280 281 280 281 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 318 327 318 327 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 53 65 <span type="species:ncbi:9606">participants</span>
###xml 120 132 <span type="species:ncbi:9606">participants</span>
###xml 318 327 <span type="species:ncbi:210">H. pylori</span>
###xml 372 384 <span type="species:ncbi:9606">participants</span>
The prevalence of atrophic gastritis was 9/101 among participants with incident cardiovascular diseases and 7/337 among participants not diagnosed with any cardiovascular disease during follow-up (P = 0.004). Corresponding figures for dementia were 3/25 and 18/463, respectively (P = 0.09). The prevalence of positive H. pylori status did not differ significantly between participants with and without incident cardiovascular diseases or dementia.
###end p 42
###begin p 43
###xml 178 179 176 177 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 235 236 233 234 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">4</xref>
###xml 237 244 235 242 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;4</label>
###xml 245 246 243 244 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">-</bold>
###xml 244 357 242 355 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">S<bold>-</bold>homocysteine concentrations at baseline in participants diagnosed with cardiovascular diseases during follow-up</p>
###xml 244 357 242 355 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44">S<bold>-</bold>homocysteine concentrations at baseline in participants diagnosed with cardiovascular diseases during follow-up</p></caption>
###xml 357 366 355 364 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Diagnosis</th>
###xml 366 394 364 392 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No. of participants examined</th>
###xml 394 434 392 431 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">S-homocysteine, &#956;mol/l median (min&#8211;max)</th>
###xml 434 435 431 432 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 441 442 438 439 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 434 509 431 506 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic>-value<sup>a</sup> when compared to participants with no known cardiovascular disease</th>
###xml 357 509 355 506 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Diagnosis</th><th align="left">No. of participants examined</th><th align="left">S-homocysteine, &#956;mol/l median (min&#8211;max)</th><th align="left"><italic>P</italic>-value<sup>a</sup> when compared to participants with no known cardiovascular disease</th></tr>
###xml 357 509 355 506 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Diagnosis</th><th align="left">No. of participants examined</th><th align="left">S-homocysteine, &#956;mol/l median (min&#8211;max)</th><th align="left"><italic>P</italic>-value<sup>a</sup> when compared to participants with no known cardiovascular disease</th></tr></thead>
###xml 509 567 506 564 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No known cardiovascular disease (hypertension disregarded)</td>
###xml 567 570 564 567 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">331</td>
###xml 570 585 567 582 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12.1 (2.9&#8211;48.3)</td>
###xml 585 585 582 582 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 509 585 506 582 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">No known cardiovascular disease (hypertension disregarded)</td><td char="." align="char">331</td><td char="." align="char">12.1 (2.9&#8211;48.3)</td><td align="left"/></tr>
###xml 585 606 582 603 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Myocardial infarction</td>
###xml 606 608 603 605 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">26</td>
###xml 608 623 605 620 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15.1 (8.7&#8211;37.3)</td>
###xml 623 629 620 626 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.001</td>
###xml 585 629 582 626 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Myocardial infarction</td><td char="." align="char">26</td><td char="." align="char">15.1 (8.7&#8211;37.3)</td><td char="." align="char">&lt;0.001</td></tr>
###xml 629 669 626 666 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ischemic heart disease (angina pectoris)</td>
###xml 669 671 666 668 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">17</td>
###xml 671 686 668 683 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13.0 (7.3&#8211;25.6)</td>
###xml 686 690 683 687 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.24</td>
###xml 629 690 626 687 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Ischemic heart disease (angina pectoris)</td><td char="." align="char">17</td><td char="." align="char">13.0 (7.3&#8211;25.6)</td><td char="." align="char">0.24</td></tr>
###xml 690 705 687 702 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Aortic Aneurysm</td>
###xml 705 706 702 703 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 706 722 703 719 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21.0 (10.7&#8211;24.2)</td>
###xml 722 726 719 723 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 690 726 687 723 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Aortic Aneurysm</td><td char="." align="char">5</td><td char="." align="char">21.0 (10.7&#8211;24.2)</td><td char="." align="char">0.02</td></tr>
###xml 726 739 723 736 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">TIA or stroke</td>
###xml 739 741 736 738 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">18</td>
###xml 741 756 738 753 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11.7 (4.6&#8211;35.7)</td>
###xml 756 760 753 757 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.91</td>
###xml 726 760 723 757 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">TIA or stroke</td><td char="." align="char">18</td><td char="." align="char">11.7 (4.6&#8211;35.7)</td><td char="." align="char">0.91</td></tr>
###xml 760 793 757 790 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Cardiac failure and/or arrhythmia</td>
###xml 793 795 790 792 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">32</td>
###xml 795 810 792 807 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13.2 (6.9&#8211;28.4)</td>
###xml 810 814 807 811 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.15</td>
###xml 760 814 757 811 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Cardiac failure and/or arrhythmia</td><td char="." align="char">32</td><td char="." align="char">13.2 (6.9&#8211;28.4)</td><td char="." align="char">0.15</td></tr>
###xml 509 814 506 811 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">No known cardiovascular disease (hypertension disregarded)</td><td char="." align="char">331</td><td char="." align="char">12.1 (2.9&#8211;48.3)</td><td align="left"/></tr><tr><td align="left">Myocardial infarction</td><td char="." align="char">26</td><td char="." align="char">15.1 (8.7&#8211;37.3)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Ischemic heart disease (angina pectoris)</td><td char="." align="char">17</td><td char="." align="char">13.0 (7.3&#8211;25.6)</td><td char="." align="char">0.24</td></tr><tr><td align="left">Aortic Aneurysm</td><td char="." align="char">5</td><td char="." align="char">21.0 (10.7&#8211;24.2)</td><td char="." align="char">0.02</td></tr><tr><td align="left">TIA or stroke</td><td char="." align="char">18</td><td char="." align="char">11.7 (4.6&#8211;35.7)</td><td char="." align="char">0.91</td></tr><tr><td align="left">Cardiac failure and/or arrhythmia</td><td char="." align="char">32</td><td char="." align="char">13.2 (6.9&#8211;28.4)</td><td char="." align="char">0.15</td></tr></tbody>
###xml 357 814 355 811 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Diagnosis</th><th align="left">No. of participants examined</th><th align="left">S-homocysteine, &#956;mol/l median (min&#8211;max)</th><th align="left"><italic>P</italic>-value<sup>a</sup> when compared to participants with no known cardiovascular disease</th></tr></thead><tbody><tr><td align="left">No known cardiovascular disease (hypertension disregarded)</td><td char="." align="char">331</td><td char="." align="char">12.1 (2.9&#8211;48.3)</td><td align="left"/></tr><tr><td align="left">Myocardial infarction</td><td char="." align="char">26</td><td char="." align="char">15.1 (8.7&#8211;37.3)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Ischemic heart disease (angina pectoris)</td><td char="." align="char">17</td><td char="." align="char">13.0 (7.3&#8211;25.6)</td><td char="." align="char">0.24</td></tr><tr><td align="left">Aortic Aneurysm</td><td char="." align="char">5</td><td char="." align="char">21.0 (10.7&#8211;24.2)</td><td char="." align="char">0.02</td></tr><tr><td align="left">TIA or stroke</td><td char="." align="char">18</td><td char="." align="char">11.7 (4.6&#8211;35.7)</td><td char="." align="char">0.91</td></tr><tr><td align="left">Cardiac failure and/or arrhythmia</td><td char="." align="char">32</td><td char="." align="char">13.2 (6.9&#8211;28.4)</td><td char="." align="char">0.15</td></tr></tbody></table>
###xml 814 815 811 812 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 814 834 811 831 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="45"><sup>a</sup>Mann&#8211;Whitney U-test</p>
###xml 814 834 811 831 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="45"><sup>a</sup>Mann&#8211;Whitney U-test</p></table-wrap-foot>
###xml 237 834 235 831 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab4"><label>Table&#160;4</label><caption><p textid="44">S<bold>-</bold>homocysteine concentrations at baseline in participants diagnosed with cardiovascular diseases during follow-up</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Diagnosis</th><th align="left">No. of participants examined</th><th align="left">S-homocysteine, &#956;mol/l median (min&#8211;max)</th><th align="left"><italic>P</italic>-value<sup>a</sup> when compared to participants with no known cardiovascular disease</th></tr></thead><tbody><tr><td align="left">No known cardiovascular disease (hypertension disregarded)</td><td char="." align="char">331</td><td char="." align="char">12.1 (2.9&#8211;48.3)</td><td align="left"/></tr><tr><td align="left">Myocardial infarction</td><td char="." align="char">26</td><td char="." align="char">15.1 (8.7&#8211;37.3)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Ischemic heart disease (angina pectoris)</td><td char="." align="char">17</td><td char="." align="char">13.0 (7.3&#8211;25.6)</td><td char="." align="char">0.24</td></tr><tr><td align="left">Aortic Aneurysm</td><td char="." align="char">5</td><td char="." align="char">21.0 (10.7&#8211;24.2)</td><td char="." align="char">0.02</td></tr><tr><td align="left">TIA or stroke</td><td char="." align="char">18</td><td char="." align="char">11.7 (4.6&#8211;35.7)</td><td char="." align="char">0.91</td></tr><tr><td align="left">Cardiac failure and/or arrhythmia</td><td char="." align="char">32</td><td char="." align="char">13.2 (6.9&#8211;28.4)</td><td char="." align="char">0.15</td></tr></tbody></table><table-wrap-foot><p textid="45"><sup>a</sup>Mann&#8211;Whitney U-test</p></table-wrap-foot></table-wrap>
###xml 37 49 <span type="species:ncbi:9606">participants</span>
###xml 289 301 <span type="species:ncbi:9606">participants</span>
###xml 373 385 <span type="species:ncbi:9606">participants</span>
###xml 460 472 <span type="species:ncbi:9606">participants</span>
S-Hcy was found to be elevated among participants developing cardiovascular diseases (14.4 (4.6-37.3) mumol/l) compared to those without such diseases (12.1 (2.9-48.3) mumol/l) (P = 0.001). S-Hcy levels in subgroups are shown in Table 4.Table 4S-homocysteine concentrations at baseline in participants diagnosed with cardiovascular diseases during follow-upDiagnosisNo. of participants examinedS-homocysteine, mumol/l median (min-max)P-valuea when compared to participants with no known cardiovascular diseaseNo known cardiovascular disease (hypertension disregarded)33112.1 (2.9-48.3)Myocardial infarction2615.1 (8.7-37.3)<0.001Ischemic heart disease (angina pectoris)1713.0 (7.3-25.6)0.24Aortic Aneurysm521.0 (10.7-24.2)0.02TIA or stroke1811.7 (4.6-35.7)0.91Cardiac failure and/or arrhythmia3213.2 (6.9-28.4)0.15aMann-Whitney U-test
###end p 43
###begin p 44
###xml 1 2 1 2 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">-</bold>
###xml 45 57 <span type="species:ncbi:9606">participants</span>
S-homocysteine concentrations at baseline in participants diagnosed with cardiovascular diseases during follow-up
###end p 44
###begin p 45
###xml 0 1 0 1 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aMann-Whitney U-test
###end p 45
###begin p 46
###xml 154 155 152 153 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 533 534 527 528 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 587 588 581 582 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 56 68 <span type="species:ncbi:9606">participants</span>
###xml 123 135 <span type="species:ncbi:9606">participants</span>
###xml 453 465 <span type="species:ncbi:9606">participants</span>
The median for S-Hcy was 15.7 (11.2-28.4) mumol/l among participants developing dementia and 12.7 (2.9-50.0) mumol/l among participants without dementia (P = 0.004). With regard to the subgroups, S-Hcy was 20.0 (12.0-23.1) mumol/l in vascular dementia, 16.2 (12.2-25.3) mumol/l in Alzheimer's disease, 11.9 (11.2-12.5) mumol/l in mixed dementia and 16.7 (12.2-28.4) mumol/l in non-specified dementia. The difference of their S-Hcy levels in relation to participants without dementia was close to significant for Alzheimer's disease (P = 0.05) and significant for non-specified dementia (P = 0.004).
###end p 46
###begin p 47
###xml 6 7 6 7 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab5" ref-type="table">5</xref>
###xml 561 562 561 562 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab5" ref-type="table">5</xref>
###xml 662 669 662 669 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;5</label>
###xml 669 828 669 828 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">Associations of S-Hcy levels with risk of cardiovascular diseases grouped together (A) and dementia subgroups considered together (B) as the dependent variable</p>
###xml 669 828 669 828 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48">Associations of S-Hcy levels with risk of cardiovascular diseases grouped together (A) and dementia subgroups considered together (B) as the dependent variable</p></caption>
###xml 828 851 828 851 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Cut-off level for S-Hcy</th>
###xml 851 887 851 887 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Odds ratio [95% confidence interval]</th>
###xml 828 887 828 887 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">Cut-off level for S-Hcy</th><th align="left" colspan="2">Odds ratio [95% confidence interval]</th></tr>
###xml 887 888 887 888 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A</th>
###xml 888 889 888 889 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">B</th>
###xml 887 889 887 889 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">A</th><th align="left">B</th></tr>
###xml 828 889 828 889 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">Cut-off level for S-Hcy</th><th align="left" colspan="2">Odds ratio [95% confidence interval]</th></tr><tr><th align="left">A</th><th align="left">B</th></tr></thead>
###xml 889 901 889 900 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14.0&#160;&#956;mol/l</td>
###xml 901 917 900 916 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.81 [1.01&#8211;3.23]</td>
###xml 917 933 916 932 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.50 [0.50&#8211;4.46]</td>
###xml 889 933 889 932 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">14.0&#160;&#956;mol/l</td><td char="." align="char">1.81 [1.01&#8211;3.23]</td><td char="." align="char">1.50 [0.50&#8211;4.46]</td></tr>
###xml 933 945 932 943 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14.5&#160;&#956;mol/l</td>
###xml 945 961 943 959 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.05 [1.14&#8211;3.70]</td>
###xml 961 977 959 975 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.92 [0.64&#8211;5.79]</td>
###xml 933 977 932 975 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">14.5&#160;&#956;mol/l</td><td char="." align="char">2.05 [1.14&#8211;3.70]</td><td char="." align="char">1.92 [0.64&#8211;5.79]</td></tr>
###xml 977 989 975 986 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15.0&#160;&#956;mol/l</td>
###xml 989 1005 986 1002 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.74 [0.96&#8211;3.16]</td>
###xml 1005 1021 1002 1018 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.90 [0.63&#8211;5.68]</td>
###xml 977 1021 975 1018 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">15.0&#160;&#956;mol/l</td><td char="." align="char">1.74 [0.96&#8211;3.16]</td><td char="." align="char">1.90 [0.63&#8211;5.68]</td></tr>
###xml 1021 1044 1018 1041 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">None (S-Hcy continuous)</td>
###xml 1044 1060 1041 1057 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.06 [1.00&#8211;1.12]</td>
###xml 1060 1076 1057 1073 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.09 [0.99&#8211;1.20]</td>
###xml 1021 1076 1018 1073 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">None (S-Hcy continuous)</td><td char="." align="char">1.06 [1.00&#8211;1.12]</td><td char="." align="char">1.09 [0.99&#8211;1.20]</td></tr>
###xml 889 1076 889 1073 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">14.0&#160;&#956;mol/l</td><td char="." align="char">1.81 [1.01&#8211;3.23]</td><td char="." align="char">1.50 [0.50&#8211;4.46]</td></tr><tr><td align="left">14.5&#160;&#956;mol/l</td><td char="." align="char">2.05 [1.14&#8211;3.70]</td><td char="." align="char">1.92 [0.64&#8211;5.79]</td></tr><tr><td align="left">15.0&#160;&#956;mol/l</td><td char="." align="char">1.74 [0.96&#8211;3.16]</td><td char="." align="char">1.90 [0.63&#8211;5.68]</td></tr><tr><td align="left">None (S-Hcy continuous)</td><td char="." align="char">1.06 [1.00&#8211;1.12]</td><td char="." align="char">1.09 [0.99&#8211;1.20]</td></tr></tbody>
###xml 828 1076 828 1073 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Cut-off level for S-Hcy</th><th align="left" colspan="2">Odds ratio [95% confidence interval]</th></tr><tr><th align="left">A</th><th align="left">B</th></tr></thead><tbody><tr><td align="left">14.0&#160;&#956;mol/l</td><td char="." align="char">1.81 [1.01&#8211;3.23]</td><td char="." align="char">1.50 [0.50&#8211;4.46]</td></tr><tr><td align="left">14.5&#160;&#956;mol/l</td><td char="." align="char">2.05 [1.14&#8211;3.70]</td><td char="." align="char">1.92 [0.64&#8211;5.79]</td></tr><tr><td align="left">15.0&#160;&#956;mol/l</td><td char="." align="char">1.74 [0.96&#8211;3.16]</td><td char="." align="char">1.90 [0.63&#8211;5.68]</td></tr><tr><td align="left">None (S-Hcy continuous)</td><td char="." align="char">1.06 [1.00&#8211;1.12]</td><td char="." align="char">1.09 [0.99&#8211;1.20]</td></tr></tbody></table>
###xml 1219 1220 1216 1217 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1076 1373 1073 1370 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="49">Results are from logistic regression analysis adjusting for gender, age at baseline (years), follow-up interval (months), body mass index (kg/m<sup>2</sup>), current smoking (yes/no), alcohol use (weekly use yes/no), use of NSAID (weekly use yes/no), P-total cholesterol (mmol/l) and P-triglycerides (mmol/l)</p>
###xml 1076 1373 1073 1370 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="49">Results are from logistic regression analysis adjusting for gender, age at baseline (years), follow-up interval (months), body mass index (kg/m<sup>2</sup>), current smoking (yes/no), alcohol use (weekly use yes/no), use of NSAID (weekly use yes/no), P-total cholesterol (mmol/l) and P-triglycerides (mmol/l)</p></table-wrap-foot>
###xml 662 1373 662 1370 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab5"><label>Table&#160;5</label><caption><p textid="48">Associations of S-Hcy levels with risk of cardiovascular diseases grouped together (A) and dementia subgroups considered together (B) as the dependent variable</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Cut-off level for S-Hcy</th><th align="left" colspan="2">Odds ratio [95% confidence interval]</th></tr><tr><th align="left">A</th><th align="left">B</th></tr></thead><tbody><tr><td align="left">14.0&#160;&#956;mol/l</td><td char="." align="char">1.81 [1.01&#8211;3.23]</td><td char="." align="char">1.50 [0.50&#8211;4.46]</td></tr><tr><td align="left">14.5&#160;&#956;mol/l</td><td char="." align="char">2.05 [1.14&#8211;3.70]</td><td char="." align="char">1.92 [0.64&#8211;5.79]</td></tr><tr><td align="left">15.0&#160;&#956;mol/l</td><td char="." align="char">1.74 [0.96&#8211;3.16]</td><td char="." align="char">1.90 [0.63&#8211;5.68]</td></tr><tr><td align="left">None (S-Hcy continuous)</td><td char="." align="char">1.06 [1.00&#8211;1.12]</td><td char="." align="char">1.09 [0.99&#8211;1.20]</td></tr></tbody></table><table-wrap-foot><p textid="49">Results are from logistic regression analysis adjusting for gender, age at baseline (years), follow-up interval (months), body mass index (kg/m<sup>2</sup>), current smoking (yes/no), alcohol use (weekly use yes/no), use of NSAID (weekly use yes/no), P-total cholesterol (mmol/l) and P-triglycerides (mmol/l)</p></table-wrap-foot></table-wrap>
Table 5A shows the results of the logistic regression analyses with cardiovascular diseases considered together as the dependent variable and S-Hcy as a continuous or dichotomous independent variable with different cut-off levels. Exchanging S-Hcy in this model for gastric mucosal atrophy (as determined morphologically or with PGI/PGII), MTHFR 677 TT genotype and elevated cystatin C taken together as an independent variable, showed no significant relation to cardiovascular diseases (OR 1.70 [0.92-3.13] with morphological determination). As shown in Table 5B, there was no significant association between S-Hcy and subgroups of dementia considered together.Table 5Associations of S-Hcy levels with risk of cardiovascular diseases grouped together (A) and dementia subgroups considered together (B) as the dependent variableCut-off level for S-HcyOdds ratio [95% confidence interval]AB14.0 mumol/l1.81 [1.01-3.23]1.50 [0.50-4.46]14.5 mumol/l2.05 [1.14-3.70]1.92 [0.64-5.79]15.0 mumol/l1.74 [0.96-3.16]1.90 [0.63-5.68]None (S-Hcy continuous)1.06 [1.00-1.12]1.09 [0.99-1.20]Results are from logistic regression analysis adjusting for gender, age at baseline (years), follow-up interval (months), body mass index (kg/m2), current smoking (yes/no), alcohol use (weekly use yes/no), use of NSAID (weekly use yes/no), P-total cholesterol (mmol/l) and P-triglycerides (mmol/l)
###end p 47
###begin p 48
Associations of S-Hcy levels with risk of cardiovascular diseases grouped together (A) and dementia subgroups considered together (B) as the dependent variable
###end p 48
###begin p 49
###xml 143 144 143 144 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Results are from logistic regression analysis adjusting for gender, age at baseline (years), follow-up interval (months), body mass index (kg/m2), current smoking (yes/no), alcohol use (weekly use yes/no), use of NSAID (weekly use yes/no), P-total cholesterol (mmol/l) and P-triglycerides (mmol/l)
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 348 350 348 350 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 588 590 588 590 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 419 431 <span type="species:ncbi:9606">participants</span>
As is the case with most population-based cohorts, one may question whether the present one is representative. The incidence of myocardial infarction found was at approximately the same level as reported by the Swedish National Board of Health and Welfare (). Also, the incidence of dementia was at the same level as previously reported in Sweden [26]. However, considering the invasive character of the EGD, which the participants were asked to undergo, the participation rate became relatively low and there may have been a selection bias based on the occurrence of digestive symptoms [21].
###end p 51
###begin p 52
###xml 82 88 <span type="species:ncbi:9606">person</span>
###xml 132 138 <span type="species:ncbi:9606">person</span>
###xml 714 726 <span type="species:ncbi:9606">participants</span>
A strength of the study is its long follow-up interval of 10 years overall (4,796 person years for cardiovascular disease and 5,262 person years for dementia) and that, in addition to relations of Hcy to disease development, it includes main determinants of Hcy levels. The evaluation of these relations was enhanced by the access to data on known relevant confounders. Another strength of the study is the reliability of the files of the Swedish National Board of Health and Welfare in which personal identification numbers are linked to in-hospital diagnoses () and, furthermore, that the information obtained from these files was verified or supplemented by information from the local hospital files and by the participants themselves.
###end p 52
###begin p 53
###xml 404 405 404 405 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 407 409 407 409 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 411 413 411 413 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 415 417 415 417 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 418 420 418 420 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 695 696 695 696 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 820 822 820 822 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 824 826 824 826 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
Regarding determinants of Hcy levels in circulation, the GLM analysis showed a positive relation of S-Hcy to age, male gender, MTHFR 677 TT genotype and atrophic gastritis (both as determined morphologically and functionally with PGI/PGII). Not unexpectedly, there was a negative relation of S-Hcy to renal function, S-vitamin B12, and S-folate. These findings are in accord with those in other studies [2, 16, 17, 27-31], although no single study evaluated all these parameters. We found no significant association between the MTHFR 677 TT genotype and Hcy levels in the univariate analysis. This is not in agreement with a previous study showing an association with mild hyperhomocysteinemia [1]. However, recent studies have shown a reduced effect of the MTHFR 677 TT genotype in populations with high folate intake [32, 33]. In the GLM analysis in the present study, this SNP had a significant impact on Hcy levels. The appearance of this significance may be explained by the inclusion of S-folate in the model.
###end p 53
###begin p 54
###xml 33 42 33 42 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 218 227 218 227 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">H.&#160;pylori</italic>
###xml 276 278 276 278 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 280 282 280 282 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 33 42 <span type="species:ncbi:210">H. pylori</span>
###xml 218 227 <span type="species:ncbi:210">H. pylori</span>
Inclusion in the GLM analysis of H. pylori-associated chronic gastritis without atrophy of the corpus mucosa did not show any significant relation to S-Hcy. This is in agreement with the finding of others, namely that H. pylori per se has no significant impact on Hcy levels [34, 35].
###end p 54
###begin p 55
###xml 198 199 198 199 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 201 202 201 202 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 204 206 204 206 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
There was no significant relation of S-Hcy to the occurrence of atrophy of the duodenal mucosa, DM, or hypothyreosis in the GLM analysis. Others have found increased S-Hcy levels in these diseases [5, 6, 29]. Since the number of cases in these groups in the present study was small, we do not draw any conclusions regarding their impact on Hcy levels.
###end p 55
###begin p 56
When using dichotomized values of S-Hcy with a cut-off level of 14.5 mumol/l we found a positive correlation between S-Hcy and the incidence of cardiovascular diseases; in fact, the risk was doubled (OR 2.05 [1.14-3.70]). With S-Hcy as continuous variable the relation was weaker (OR 1.06 [1.00-1.12]). Exchanging S-Hcy for its explanatory variables, atrophic gastritis, MTHFR 677 TT genotype and elevated cystatin C taken together as an independent variable in the analysis yielded a weak association, if any (OR 1.70 [0.92-3.13]). Since there are other causes of variations in Hcy levels than those studied here, this lack of an association is not unexpected.
###end p 56
###begin p 57
###xml 216 218 216 218 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 219 221 219 221 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 249 251 249 251 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 530 532 529 531 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 723 725 721 723 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 1260 1262 1257 1259 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 1319 1321 1316 1318 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">42</xref>
###xml 303 306 <span type="species:ncbi:9606">men</span>
###xml 798 801 <span type="species:ncbi:9606">men</span>
###xml 1343 1346 <span type="species:ncbi:9606">men</span>
Considering the relation of Hcy to cardiovascular diseases, our results are in accordance with findings in other prospective studies, although the cut-off levels for Hcy concentrations used vary between the studies [36-41]. In one of these studies [36], which included 229 cases and 1,126 controls (all men, mean follow-up time 8.7 years), there was a continuous dose-response relationship with a 41% (20%-65%) increased risk of death from ischemic heart disease for each 5-mumol/l increase in the S-Hcy level. In an other study [37] of 122 cases and 478 controls, the relative risk of ischemic heart disease hospital discharges and deaths resulting from a 4 mumol/l increase in S-Hcy was 1.32 (1.05-1.65). Whincup et al. [41], who followed a population for 12.8 years (386 cases and 454 controls, men aged 40-59 years at entry), found that a 47% increase in S-Hcy was associated with a slight increase in the OR for myocardial infarction of 1.15 (1.00-1.32). For values of S-Hcy higher than 16.5 mumol/l, the OR for myocardial infarction was 1.77 (1.28-2.42). As shown in the comprehensive meta-analysis conducted by the Homocysteine Studies Collaboration, there are also prospective studies that show no correlation of Hcy levels to cardiovascular diseases [40]. This was also the case in the study by Fallon et al. [42], which included 312 men with coronary heart disease and 1,248 matched controls.
###end p 57
###begin p 58
###xml 408 410 408 410 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 767 769 767 769 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
###xml 309 321 <span type="species:ncbi:9606">participants</span>
###xml 327 332 <span type="species:ncbi:9606">women</span>
###xml 341 344 <span type="species:ncbi:9606">men</span>
###xml 736 748 <span type="species:ncbi:9606">participants</span>
Although according to the results of univariate analysis in the present study, S-Hcy levels seemed to be elevated in subgroups with dementia, including dementia overall as dependent variable in the logistic regression analysis yielded no significant association to Hcy levels. In a prospective study of 1,092 participants (667 women and 425 men) with a median follow-up interval of 8 years, Seshadri et al. [11] found that increased P-Hcy is an independent risk factor for dementia and Alzheimer's disease. The relative risk of dementia was 1.4 (1.1-1.9) for each increase of one SD in logarithmically transformed Hcy values. The corresponding figure for Alzheimer's disease was 1.8 (1.3-2.5). In an Italian dementia-free cohort of 816 participants, Ravaglia et al. [43] related baseline P-Hcy to incident dementia, including Alzheimer's disease, during a mean follow-up interval of 4 years. They concluded that increased Hcy and low folate concentrations are independent risk factors. Hyperhomocysteinemia was considered to be present with a P-Hcy higher than 15.0 mumol/l. With this cut-off level the hazard ratio for dementia was 2.08.
###end p 58
###begin p 59
To summarize, in this population-based cohort Hcy concentrations in circulation were dependent on gender, age, the levels of vitamin B12 and folate, as well as on renal function, the occurrence of atrophic gastritis and the MTHFR 677 TT genotype. There was a positive relation of Hcy levels to incident cardiovascular diseases.
###end p 59
###begin p 60
This study was supported by grants from the Swedish Cancer Society and the Research Council in the South East of Sweden (FORSS).
###end p 60
###begin p 61
###xml 0 11 0 11 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 61
###begin title 62
References
###end title 62
###begin article-title 63
Homocysteine metabolism
###end article-title 63
###begin article-title 64
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
###end article-title 64
###begin article-title 65
Homocysteine, a risk factor for cardiovascular disease
###end article-title 65
###begin article-title 66
Hyperhomocysteinaemia-a common finding in a psychogeriatric population
###end article-title 66
###begin article-title 67
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus
###end article-title 67
###begin article-title 68
Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon
###end article-title 68
###begin article-title 69
Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
###end article-title 69
###begin article-title 70
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function
###end article-title 70
###begin article-title 71
Homocysteinemia as a risk factor for atherosclerosis: a review
###end article-title 71
###begin article-title 72
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
###end article-title 72
###begin article-title 73
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
###end article-title 73
###begin article-title 74
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Folate deficiency is a common finding in psychogeriatric patients
###end article-title 74
###begin article-title 75
###xml 20 40 20 40 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Helicobacter pylori</italic>
###xml 21 40 <span type="species:ncbi:210">Helicobacter pylori</span>
The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration
###end article-title 75
###begin article-title 76
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
###end article-title 76
###begin article-title 77
Facts and recommendations about total homocysteine determinations: an expert opinion
###end article-title 77
###begin article-title 78
Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics
###end article-title 78
###begin article-title 79
Homocysteine and related B-vitamin status in coeliac disease: effects of gluten exclusion and histological recovery
###end article-title 79
###begin article-title 80
###xml 23 42 <span type="species:ncbi:210">Helicobacter pylori</span>
An association between Helicobacter pylori infection and serum vitamin B12 levels in healthy adults
###end article-title 80
###begin article-title 81
###xml 11 31 11 31 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Helicobacter pylori</italic>
###xml 12 31 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography
###end article-title 81
###begin article-title 82
###xml 58 78 58 78 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Helicobacter pylori</italic>
###xml 59 78 <span type="species:ncbi:210">Helicobacter pylori</span>
Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies
###end article-title 82
###begin article-title 83
###xml 34 54 34 54 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Helicobacter pylori</italic>
###xml 35 54 <span type="species:ncbi:210">Helicobacter pylori</span>
Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: relations to symptomatology and life-style
###end article-title 83
###begin article-title 84
###xml 46 66 46 66 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Helicobacter pylori</italic>
###xml 47 66 <span type="species:ncbi:210">Helicobacter pylori</span>
Prevalence of coeliac disease and relations to Helicobacter pylori infection and duodenitits in a Swedish adult population sample: a histomorphological and serological survey
###end article-title 84
###begin article-title 85
Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994
###end article-title 85
###begin article-title 86
Dermatitis herpetiformis
###end article-title 86
###begin article-title 87
###xml 64 69 <span type="species:ncbi:9606">human</span>
Multiple strand displacement amplification of DNA isolated from human archival plasma/serum: identification of cytokine polymorphism by pyrosequencing analysis
###end article-title 87
###begin article-title 88
Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group
###end article-title 88
###begin article-title 89
###xml 0 19 0 19 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori</italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Helicobacter pylori eradication lowers serum homocysteine level in patients without gastric atrophy
###end article-title 89
###begin article-title 90
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Prevalence and mechanisms of hyperhomocysteinemia in elderly hospitalized patients
###end article-title 90
###begin article-title 91
Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk
###end article-title 91
###begin article-title 92
###xml 132 151 <span type="species:ncbi:210">Helicobacter pylori</span>
Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection
###end article-title 92
###begin article-title 93
The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels
###end article-title 93
###begin article-title 94
Meta-analysis of MTHFR 677C-&T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?
###end article-title 94
###begin article-title 95
The Hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease
###end article-title 95
###begin article-title 96
Atrophic gastritis as a cause of hyperhomocysteinaemia
###end article-title 96
###begin article-title 97
###xml 19 39 19 39 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"> Helicobacter pylori</italic>
###xml 20 39 <span type="species:ncbi:210">Helicobacter pylori</span>
Correlation between Helicobacter pylori infection, gastric inflammation and serum homocysteine concentration
###end article-title 97
###begin article-title 98
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention
###end article-title 98
###begin article-title 99
Serum total homocysteine and coronary heart disease
###end article-title 99
###begin article-title 100
###xml 93 96 <span type="species:ncbi:9606">men</span>
Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up
###end article-title 100
###begin article-title 101
Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam study
###end article-title 101
###begin article-title 102
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis
###end article-title 102
###begin article-title 103
###xml 86 89 <span type="species:ncbi:9606">men</span>
Serum total homocysteine and coronary heart disease: prospective study in middle-aged men
###end article-title 103
###begin article-title 104
Homocysteine and coronary heart disease in the Caerphilly cohort: a 10-year follow-up
###end article-title 104
###begin article-title 105
Homocysteine and folate as risk factors for dementia and Alzheimer disease
###end article-title 105

